Erythrodermic psoriasis precipitated by radiologic contrast media.
Evans
A V
AV
Parker
J C
JC
Russell-Jones
R
R
D000284:Administration, Oral; D002430:Cecal Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007262:Infusions, Intravenous; D007479:Iopamidol / Q000008:administration & dosage / Q000009:adverse effects*; D008113:Liver Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary; D008875:Middle Aged; D011565:Psoriasis / Q000139:chemically induced* / Q000188:drug therapy; D011929:Razoxane / Q000008:administration & dosage / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
D003287:Contrast Media; D007166:Immunosuppressive Agents; D011929:Razoxane; D007479:Iopamidol